Structure & organization

Ευστάθιος Γκόνος

ICB Director

Δρ Θεοδώρα Καλογεροπούλου

Deputy Director of ICB

Scientific Council of ICB (2024-2026)

Dr. Spyros Zographos

President

Dr. Niki Chondrogianni

Member

Dr. Theodora Katsila

Member

Dr. Vasiliki Pletsa

Member

Dr. Maria Zoumpanioti

Alternate Member

Dr. Evangelia Chrysina

Alternate Member

George Sotiroudis, M.Sc.

Representative of ICB Scientific Technical and Administrative Personnel

International Scientific Advisory Board

Rene Bernards

Netherlands Cancer Institute, NL

Mark Bradley

University of Edinburgh, UK

Ian Collins

The Institute of Cancer Research, London, UK

Nissim Garti

The Hebrew University of Jerusalem, Israel

Spiros Linardopoulos

The Institute of Cancer Research, London, UK

Stefano Mangani

University of Siena, IT

Secretary

Fotini Kalatzi

Grant Management Support Team

Maria Papadopoulou

Konstantinos Triantafyllopoulos

Chief Technical Scientist

Stella Kaila, M.Sc.

 The Director of the ICB is elected for a four-year term by an external committee appointed by the National Council for Research, Technology and Innovation (NCRTI). He/She is responsible for the implementation of the development, research strategy of the Institute and its exploitation (in collaboration with the SCI of the ICB, see below), ensures its smooth operation, the preparation of the annual budget and represents the ICB on the Board of Directors of the NHRF. In case of absence, the Director is replaced by the Deputy Director.

The Director is assisted by the Scientific Council of the Institute (SCI) whose members are elected every two years by the ICB personnel. The SCI monitors the Institute’s research and development program, contributes to shaping the strategy, organization chart and human resources policy, evaluates the research work of the Institute and contributes substantially to its evaluation process.

An International Scientific Advisory Board (ISAB) offers valuable advice for the widening of the mission, the goals and the organization of ICB. The ISAB comprises six internationally recognized scientists in the fields of Chemical Biology, Drug discovery, Prognostic/Predictive biomarkers and Biotechnology.

Meetings of the general assembly of the ICB (permanent staff) are held ideally every 6 months.

Administrative support is provided by one permanent secretary and two additional administrators for ICB’s grant management support. A chief technical scientist efficiently orchestrates the functional operation of the Institute and resolves any emerging technical and safety issues.

Institute of Chemical Biology Organization Chart

Ευστάθιος Γκόνος

ICB Director

Δρ Θεοδώρα Καλογεροπούλου

Deputy Director of ICB

Scientific Council of ICB (2024-2026)

Dr. Spyros Zographos

President

Dr. Niki Chondrogianni

Member

Dr. Theodora Katsila

Member

Dr. Vasiliki Pletsa

Member

Dr. Maria Zoumpanioti

Alternate Member

Dr. Evangelia Chrysina

Alternate Member

George Sotiroudis, M.Sc.

Representative of ICB Scientific Technical and Administrative Personnel

International Scientific Advisory Board

Rene Bernards

Netherlands Cancer Institute, NL

Mark Bradley

University of Edinburgh, UK

Ian Collins

The Institute of Cancer Research, London, UK

Nissim Garti

The Hebrew University of Jerusalem, Israel

Spiros Linardopoulos

The Institute of Cancer Research, London, UK

Stefano Mangani

University of Siena, IT

Secretary

Fotini Kalatzi

Grant Management Support Team

Maria Papadopoulou

Konstantinos Triantafyllopoulos

Chief Technical Scientist

Stella Kaila, M.Sc.